AstraZeneca (LSE:AZN) said on Tuesday that it plans to withdraw its American Depositary Shares and debt securities from Nasdaq and move to a direct listing on the New York Stock Exchange.
The change is scheduled to take effect after the close of trading on January 30, 2026, with AstraZeneca’s shares expected to begin trading on the NYSE from February 2. The group will continue to trade under its existing “AZN” ticker symbol following the transition.
As part of the new, harmonised structure, AstraZeneca will move away from its current American Depositary Share format, under which each ADS represents two ordinary shares. Instead, the company will list its $0.25 ordinary shares directly in the United States.
The company said the move is intended to streamline its share structure and simplify trading across its global markets.
Leave a Reply